Navigation Links
Court Certifies Overtime Class Action Against Forest Labs, According to The Ottinger Firm, P.C.
Date:6/7/2011

NEW YORK, June 7, 2011 /PRNewswire/ -- A class action alleging Forest Labs (NYSE: FRX) pharmaceutical sales representatives were unlawfully denied overtime pay has been certified by a New York federal court, The Ottinger Firm, P.C., announced today.

U.S. District Judge William H. Pauley, of the Southern District of New York, granted the plaintiffs' motion for conditional collective action certification under the federal Fair Labor Standards Act (FLSA).

The national "opt-in" class includes Forest Labs sales representatives who were employed by the company in the three years before the case was filed in August 2010. The Ottinger Firm is proposed counsel for members of the class.

The case is "Elmaria Martinez, et al., v. Forest Laboratories, Inc., et al.," Civil Action No. 10 cv 6032 (WHP) in the U.S. District Court, Southern District of New York.

The defendants are New York-based Forest Laboratories, Inc. and subsidiary Forest Pharmaceuticals, Inc. The named plaintiff, Ms. Martinez, was employed by the defendants between 2002 and 2011.

Attorney Robert W. Ottinger said, "This is a notable victory for Ms. Martinez and the Forest Labs pharmaceutical sales representatives covered by this class action. We believe the strength of this case and recent appellate court rulings confirm the overtime eligibility for these pharmaceutical sales representatives under the FLSA. We are pleased the Court conditionally certified this class action and look forward to moving forward with the case."

The Court determined that Ms. Martinez and the putative class were similarly situated in light of their common classification as exempt from overtime under the FLSA, because they shared common job descriptions and because they were subject to common employment policies, Mr. Ottinger said.

Attorney Contacts: Robert W. Ottinger and Christopher Q. Davis, The Ottinger Firm, P.C., New York, 212.571.2000, www.ottingerlaw.com.


'/>"/>
SOURCE The Ottinger Firm, P.C.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Lilly Comments on Court Ruling in Amylin Litigation
2. Federal Court Asked to Compel Decision in Marijuana Scheduling Action
3. 83 Cases of Autism Associated with Childhood Vaccine Injury Compensated in Federal Vaccine Court
4. U.S. District Court Order Maintains Patent Exclusivity for Lillys Cymbalta
5. McDonald Hopkins Law Firm Alert: Recent Court of Appeals Decision Highlights the Need to Properly Define the Role of Sales Representatives
6. Verathon Inc. GlideScope Video Laryngoscope Patent Upheld in Court
7. Watson Confirms Favorable Appeals Court Ruling on Generic SEASONIQUE® Patent Challenge
8. Watson Confirms District Court Ruling in Generic Fentora® Patent Suit
9. Heygood, Orr & Pearson: Los Angeles Court Orders Watson Pharmaceuticals to Produce Documents, Provide Depositions in Fentanyl Patch Death Lawsuit
10. Watson Announces Favorable District Court Ruling in Generic Fentora® Patent Suit
11. Court Rules on First Set of Patents in FENTORA Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... a startling report released today, National Safety Council research ... proven plan to eliminate prescription opioid overdoses. Prescription Nation ... tackling the worst drug crisis in recorded U.S. history, assigned a ... , New Mexico , Tennessee ... failing states, three – Michigan , ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Medical Market Analysis 2016 - Forecast to 2022" report ... The report contains up to date financial data derived from ... of major trends with potential impact on the market during ... market segmentation which comprises of sub markets, regional and country ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the ... to iHire in recognition of their exemplary accomplishments in worksite health promotion. , The ... Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one ...
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... today at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra ... authored journal articles published in Emergency Medicine Practice and Pediatric Emergency ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the placement ... Vice President of North American Capital Sales at HTG Molecular . ... in the commercialization of the HTG EdgeSeq system and associated reagents in North America. ...
Breaking Medicine News(10 mins):